Provided by Tiger Fintech (Singapore) Pte. Ltd.

Benitec Biopharma

15.05
+0.64004.44%
Post-market: 15.050.00000.00%16:25 EDT
Volume:64.82K
Turnover:979.19K
Market Cap:383.69M
PE:-7.77
High:15.69
Open:14.42
Low:14.42
Close:14.41
Loading ...
Dec 13, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Dec 12, 2022

Major Issues Report

8-K - Current report
Dec 08, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2022

Major Issues Report

8-K - Current report
Oct 18, 2022

Major Issues Report

8-K - Current report
Oct 11, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 07, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 23, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 16, 2022

Major Issues Report

8-K - Current report
Sep 12, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 09, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 08, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 08, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 07, 2022

Major Issues Report

8-K - Current report
Sep 02, 2022

Major Issues Report

8-K - Current report
Sep 02, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Aug 11, 2022

Correspondence

CORRESP [Cover] - Correspondence
Aug 10, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Aug 08, 2022

Correspondence

CORRESP [Cover] - Correspondence